600488 津药药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.4572.3174.4403.9501.187
总资产报酬率 ROA (%)0.2441.2322.2541.8300.545
投入资产回报率 ROIC (%)0.3551.8203.3702.6530.762

边际利润分析
销售毛利率 (%)41.97240.91745.44546.42549.073
营业利润率 (%)3.6036.5257.0154.4781.903
息税前利润/营业总收入 (%)4.8014.7187.2924.9021.132
净利润/营业总收入 (%)2.5084.1976.4764.3000.500

收益指标分析
经营活动净收益/利润总额(%)189.006208.868122.907114.5091,621.443
价值变动净收益/利润总额(%)0.882-0.654-4.014-0.669-179.255
营业外收支净额/利润总额(%)-1.389-55.3970.423-0.694-460.919

偿债能力分析
流动比率 (X)2.0761.8811.4851.0861.035
速动比率 (X)1.4721.3810.9490.7130.528
资产负债率 (%)30.59132.37931.80638.89643.557
带息债务/全部投入资本 (%)16.78818.92715.28023.92133.617
股东权益/带息债务 (%)467.326406.559524.793300.551187.495
股东权益/负债合计 (%)176.897162.704168.688123.622102.611
利息保障倍数 (X)3.8499.09329.55210.7751.428

营运能力分析
应收账款周转天数 (天)78.63651.34840.37436.73941.144
存货周转天数 (天)151.705129.463141.355167.252204.385